Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Johnson & Johnson buy Royal Bank of Canada

Start price
€135.56
17.06.24 / 50%
Target price
€163.24
17.06.25
Performance (%)
-2.11%
End price
€132.70
18.06.25
Summary
This prediction ended on 18.06.25 with a price of €132.70. With a performance of -2.11%, the BUY prediction by Royal_Bank_of_Canada finished with a loss. Royal_Bank_of_Canada has a follow-up prediction for Johnson & Johnson where he still thinks Johnson & Johnson is a Buy. Dividends of €3.48 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this prediction

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Performance without dividends (%)
Name 1w 1m 1y
Johnson & Johnson 3.001% 3.001% 1.457%
iShares Core DAX® 3.109% -0.124% 36.052%
iShares Nasdaq 100 3.088% 4.723% 20.631%
iShares Nikkei 225® 4.760% 5.051% 11.016%
iShares S&P 500 1.840% 3.430% 13.790%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Johnson & Johnson diskutieren
Prediction Buy
Perf. (%) -2.11%
Target price 163.240
Change
Ends at 17.06.25

Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $175.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

In the thread Trading Johnson & Johnson
Prediction Buy
Perf. (%) -2.11%
Target price 163.240
Change
Ends at 17.06.25

Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

Current prediction by Royal_Bank_of_Canada for Johnson & Johnson

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€147.80
20.09.24
€157.01
20.09.25
2.40%
08.08.25

Stopped prediction by Royal_Bank_of_Canada for Johnson & Johnson

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.62
17.07.25
€159.16
17.07.26
5.95%
08.08.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€134.02
05.06.25
€158.54
05.06.26
11.16%
08.08.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€135.54
16.04.25
€159.80
16.04.26
9.92%
08.08.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€142.36
02.04.25
€167.71
02.04.26
4.65%
08.08.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€150.96
19.02.25
€173.58
19.02.26
-1.31%
08.08.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.68
23.01.25
€173.71
23.01.26
6.74%
08.08.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€150.18
16.10.24
€166.19
16.10.25
0.78%
08.08.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€145.42
08.10.24
€162.10
08.10.25
4.08%
08.08.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€146.42
30.07.24
€161.96
30.07.25
-0.66%
31.07.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€135.92
04.06.24
€160.97
04.06.25
-1.32%
05.06.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.68
22.05.24
€161.46
22.05.25
-4.04%
23.05.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€141.42
16.05.24
€160.88
16.05.25
-4.53%
17.05.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€148.40
28.02.24
€167.03
28.02.25
6.13%
01.03.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€145.90
24.01.24
€166.03
24.01.25
-4.37%
25.01.25

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€143.70
01.12.23
€163.56
01.12.24
1.98%
02.12.24